DK3711758T3 - Anvendelse af en carbamatforbindelse til forebyggelse, lindring eller behandling af fraværsanfald eller epilepsi med fraværsanfald - Google Patents

Anvendelse af en carbamatforbindelse til forebyggelse, lindring eller behandling af fraværsanfald eller epilepsi med fraværsanfald Download PDF

Info

Publication number
DK3711758T3
DK3711758T3 DK18878222.1T DK18878222T DK3711758T3 DK 3711758 T3 DK3711758 T3 DK 3711758T3 DK 18878222 T DK18878222 T DK 18878222T DK 3711758 T3 DK3711758 T3 DK 3711758T3
Authority
DK
Denmark
Prior art keywords
absence seizures
epilepsy
alleviation
prevention
treatment
Prior art date
Application number
DK18878222.1T
Other languages
Danish (da)
English (en)
Inventor
Hye Won Shin
Original Assignee
Sk Biopharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=66540315&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3711758(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sk Biopharmaceuticals Co Ltd filed Critical Sk Biopharmaceuticals Co Ltd
Application granted granted Critical
Publication of DK3711758T3 publication Critical patent/DK3711758T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
DK18878222.1T 2017-11-14 2018-11-13 Anvendelse af en carbamatforbindelse til forebyggelse, lindring eller behandling af fraværsanfald eller epilepsi med fraværsanfald DK3711758T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20170151248 2017-11-14
PCT/KR2018/013761 WO2019098628A1 (ko) 2017-11-14 2018-11-13 결신 발작 또는 결신 발작을 나타내는 뇌전증의 예방, 경감 또는 치료를 위한 카바메이트 화합물의 용도

Publications (1)

Publication Number Publication Date
DK3711758T3 true DK3711758T3 (da) 2024-04-08

Family

ID=66540315

Family Applications (1)

Application Number Title Priority Date Filing Date
DK18878222.1T DK3711758T3 (da) 2017-11-14 2018-11-13 Anvendelse af en carbamatforbindelse til forebyggelse, lindring eller behandling af fraværsanfald eller epilepsi med fraværsanfald

Country Status (16)

Country Link
US (1) US20200352907A1 (https=)
EP (1) EP3711758B1 (https=)
JP (2) JP7258901B2 (https=)
KR (1) KR102739584B1 (https=)
CN (1) CN111432812A (https=)
AU (1) AU2018367729B2 (https=)
BR (1) BR112020009265A2 (https=)
CA (1) CA3081223A1 (https=)
DK (1) DK3711758T3 (https=)
ES (1) ES2982316T3 (https=)
FI (1) FI3711758T3 (https=)
IL (1) IL274428B2 (https=)
MX (1) MX2020004972A (https=)
PL (1) PL3711758T3 (https=)
PT (1) PT3711758T (https=)
WO (1) WO2019098628A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3854392A4 (en) * 2018-09-21 2022-08-17 SK Biopharmaceuticals Co., Ltd. USE OF A CARBAMATE COMPOUND TO PREVENT, RELIEVE OR TREAT CONJUNCTING SEIGES
CN116143717B (zh) * 2021-11-22 2025-05-06 康百达(四川)生物医药科技有限公司 一种氘代氨基甲酸酯化合物及其在医药上的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6383764B1 (en) 2000-04-28 2002-05-07 The Regents Of The University Of California Methods of identifying compounds for controlling absence seizures in a mammal relating to prolactin-releasing peptide(PrRP)
KR100534556B1 (ko) 2001-10-26 2005-12-08 주식회사 오리엔트바이오 알파1g 단백질의 기능을 억제하여 간질을 일으키지 않게하는 방법
EP1707204A1 (en) * 2005-04-01 2006-10-04 Bioprojet Treatment of epilepsy with non-imidazole alkylamines histamine H3-receptor ligands
US7598279B2 (en) * 2005-04-22 2009-10-06 Sk Holdings Co., Ltd. Neurotherapeutic azole compounds
WO2010150946A1 (en) * 2009-06-22 2010-12-29 Sk Holdings Co., Ltd. Method for preparation of carbamic acid (r)-1-aryl-2-tetrazolyl-ethyl ester
US8404461B2 (en) * 2009-10-15 2013-03-26 SK Biopharmaceutical Co. Ltd. Method for preparation of carbamic acid (R)-1-aryl-2-tetrazolyl-ethyl ester
US9629853B2 (en) 2014-05-21 2017-04-25 Wisconsin Alumni Research Foundation Uses of ganaxolone
KR102489052B1 (ko) 2016-05-19 2023-01-16 에스케이바이오팜 주식회사 섬유근육통 또는 섬유근육통의 연관된 기능적 증후군을 예방 또는 치료하기 위한 카바메이트 화합물의 용도
CA3046458A1 (en) 2016-12-14 2018-06-21 Sk Biopharmaceuticals Co., Ltd. Parenteral liquid preparation comprising carbamate compound
WO2019045121A1 (en) 2017-08-31 2019-03-07 Takeda Pharmaceutical Company Limited TREATMENT OF CNS DISEASES

Also Published As

Publication number Publication date
ES2982316T3 (es) 2024-10-15
CN111432812A (zh) 2020-07-17
KR102739584B1 (ko) 2024-12-06
CA3081223A1 (en) 2019-05-23
JP7578747B2 (ja) 2024-11-06
BR112020009265A2 (pt) 2020-10-20
AU2018367729A1 (en) 2020-05-21
IL274428A (en) 2020-06-30
IL274428B2 (en) 2023-08-01
JP7258901B2 (ja) 2023-04-17
JP2023085469A (ja) 2023-06-20
JP2021503010A (ja) 2021-02-04
KR20200074153A (ko) 2020-06-24
RU2020119292A3 (https=) 2022-02-24
EP3711758A4 (en) 2021-08-04
MX2020004972A (es) 2020-08-24
AU2018367729B2 (en) 2024-06-13
PT3711758T (pt) 2024-04-22
US20200352907A1 (en) 2020-11-12
EP3711758B1 (en) 2024-03-27
RU2020119292A (ru) 2021-12-15
EP3711758A1 (en) 2020-09-23
PL3711758T3 (pl) 2024-07-01
WO2019098628A1 (ko) 2019-05-23
IL274428B1 (en) 2023-04-01
FI3711758T3 (fi) 2024-05-13

Similar Documents

Publication Publication Date Title
MA47433A (fr) Composé de quinazoline
EP4220067C0 (en) THUMB LOCKING PISTOL HOLSTER
DK3501542T3 (da) Esketamin til behandling af depression
DK3261640T3 (da) 5ht-agonister til behandling af epilepsilidelser
HUE039809T2 (hu) Vegyület karbamid-tartalmú mûtrágyák kezelésére
MA47419A (fr) Mousqueton à double verrouillage
DK3624796T3 (da) Pyrrolopyridin.anilinforbindelser til behandling af hudlidelse
IL285248A (en) Tivut for use as a drug for the prevention and/or treatment of cognitive dysfunction associated with aging
IL257960A (en) A group of substances used to treat or prevent hyperuricemia or gout
EP3354638A4 (en) PHTHALODINITRILVERBINDUNG
DK3336369T3 (da) Fastgørelsesanlæg
DK3579826T3 (da) Fremgangsmåder til behandling af cdkl5-lidelser med forbindelsen ov329
DK3459543T3 (da) Carbamatforbindelse til forebyggelse eller behandling af fibromyalgi
EP3299355A4 (en) PHTHALODINITRILVERBINDUNG
DK3452583T3 (da) Konstruerede nukleaser, der er nyttige til behandling af hæmofili a
EP3438103A4 (en) Griseofulvin compound
PL3297625T3 (pl) Związek do profilaktyki lub leczenia nefropatii cukrzycowej lub cukrzycowej choroby nerek
MA43275A (fr) Composé de pyranodipyridine
DK3709996T3 (da) Coumarin-derivat til behandling eller forebyggelse af en celleproliferativ lidelse
DK3506956T3 (da) Lægemiddel, særlig til behandling af fistler
MA47569A (fr) Composé guanidine et bactéricide
EP3485921A4 (en) ADHESION PREVENTING COMPOSITION
DK3711758T3 (da) Anvendelse af en carbamatforbindelse til forebyggelse, lindring eller behandling af fraværsanfald eller epilepsi med fraværsanfald
ZA201903747B (en) Use of carbamate compounds for prevention, alleviation or treatment of bipolar disorder
DK3459542T3 (da) Anvendelse af carbamatforbindelse til forebyggelse eller behandling af trigeminusneuralgi